Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Targeting colon cancer stem cells might lead to better treatment results.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Analog 23 is a promising compound for prostate cancer treatment.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Some breast cancer chemotherapy can cause permanent hair loss.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.